- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 12-02-2026: Press Release
12-02-2026 | 07:42 pm
12-02-2026 | 07:42 pm
Biocon's Q3FY26 operating revenue rose 9% to Rs 4,173 Cr, with net profit surging 475% to Rs 144 Cr. The company fully integrated Biocon Biologics, raising Rs 4,150 Cr via QIP for the Mylan stake. Generics revenue grew 24%; Biosimilars expanded portfolio globally.
No comments yet. Be the first to comment!